Cementum is known to be growth-hormone (GH)-responsive, but to what extent is unclear. This study examines the effects of extremes of GH status on cementogenesis in three lines of genetically modified mice; GH excess (giant), GH antagonist excess (dwarf), and GH receptor-deleted (GHR-KO) (dwarf). Age-matched mandibular molar tissues were processed for light microscope histology. Digital images of sections of first molar teeth were captured for morphometric analysis of lingual root cementum. Cross-sectional area of the cellular cementum was a sensitive guide to GH status, being reduced nearly 10-fold in GHR-KO mice, three-fold in GH antagonist mice, and increased almost two-fold in giant mice (p < 0.001). Cellular cementum length was similarly influenced by GH status, but to a lesser extent. Acellular cementum was generally unaffected. This study reveals cellular cementum to be a highly responsive GH target tissue, which may have therapeutic applications in assisting regeneration of the periodontium.
Get full access to this article
View all access options for this article.
References
1.
Becks H, Collins DA, Asling CW, Simpson ME, Li CH, Evans HM (1948). The gigantism produced in normal rats by injection of the pituitary growth hormone. V. Skeletal changes: skull and dentition. Growth12:55–67.
2.
Bosshardt DD, Selvig KA (1997). Dental cementum: the dynamic tissue covering of the root. Periodontol 200013:41–75.
3.
Bronckers AL, Farach-Carson MC, Van Waveren E, Butler WT (1994). Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root formation and early cementogenesis in the rat. J Bone Miner Res9:833–841.
4.
Chen WY, White ME, Wagner TE, Kopchick JJ (1991a). Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology129:1402–1408.
5.
Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ (1991b). Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol Endocrinol5:1845–1852.
6.
Cho MI, Garant PR (2000). Development and general structure of the periodontium. Periodontol 200024:9–27.
7.
Clayden AM, Young WG, Zhang CZ, Harbrow D, Romaniuk K, Waters MJ (1994). Ultrastructure of cementogenesis as affected by growth hormone in the molar periodontium of the hypophysectomized rat. J Periodontal Res29:266–275.
8.
Cohn SA (1957). Development of the molar teeth in the albino mouse. Am J Anat101:295–319.
9.
Ducy P (2000). Cbfa1: a molecular switch in osteoblast biology. Dev Dyn219:461–471.
10.
Eckstein F, Lochmuller EM, Koller B, Wehr U, Weusten A, Rambeck W, et al. (2002). Body composition, bone mass and microstructural analysis in GH-transgenic mice reveals that skeletal changes are specific to bone compartment and gender. Growth Horm IGF Res12:116–125.
11.
Fukuta Y, Totsuka M, Fukuta Y, Takeda Y, Yoshida Y, Niitsu J, et al. (2001). Histological and analytical studies of a tooth in a patient with cleidocranial dysostosis. J Oral Sci43:85–89.
12.
Hashimoto F, Kobayashi Y, Kobayashi ET, Sakai E, Kobayashi K, Shibata M, et al. (2001). Expression and localization of MGP in rat tooth cementum. Arch Oral Biol46:585–592.
13.
Knapp JR, Chen WY, Turner ND, Byers FM, Kopchick JJ (1994). Growth patterns and body composition of transgenic mice expressing mutated bovine somatotropin genes. J Anim Sci72:2812–2819.
14.
Kopchick JJ, Bellush LL, Coschigano KT (1999). Transgenic models of growth hormone action. Annu Rev Nutr19:437–461.
15.
Lezot F, Davideau JL, Thomas B, Sharpe P, Forest N, Berdal A (2000). Epithelial Dlx-2 homeogene expression and cementogenesis. J Histochem Cytochem48:277–284.
16.
Li H, Bartold PM, Zhang CZ, Clarkson RW, Young WG, Waters MJ (1998). Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: a mediator role in bone and tooth formation? Endocrinology139:3855–3862.
17.
Li H, Bartold PM, Young WG, Xiao Y, Waters MJ (2001). Growth hormone induces bone morphogenetic proteins and bone-related proteins in the developing rat periodontium. J Bone Miner Res16:1068–1076.
18.
Ong CK, Joseph BK, Waters MJ, Symons AL (2001). Growth hormone receptor and IGF-I receptor immunoreactivity during orthodontic tooth movement in the prednisolone-treated rat. Angle Orthod71:486–493.
19.
Sarnat H, Kaplan I, Pertzelan A, Laron Z (1988). Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism. Oral Surg Oral Med Oral Pathol66:581–586.
20.
Sasano Y, Maruya Y, Sato H, Zhu JX, Takahashi I, Mizoguchi I, et al. (2001). Distinctive expression of extracellular matrix molecules at mRNA and protein levels during formation of cellular and acellular cementum in the rat. Histochem J33:91–99.
21.
Saygin NE, Giannobile WV, Somerman MJ (2000). Molecular and cell biology of cementum. Periodontol 200024:73–98.
22.
Schour I, Massler M (1943). Endocrines and dentistry. J Am Dent Assoc30:595–603.
23.
Young WG, Zhang CZ, Li H, Lobie PE, Waters MJ (1993). A bromodeoxyuridine immunocytochemical and morphometric study of the influence of growth hormone on cell proliferation in odontogenic mesenchyme of the Lewis dwarf rat. Arch Oral Biol38:207–214.
24.
Zhang CZ, Young WG, Li H, Clayden AM, Garcia-Aragon J, Waters MJ (1992). Expression of growth hormone receptor by immunocytochemistry in rat molar root formation and alveolar bone remodeling. Calcif Tissue Int50:541–546.
25.
Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ (2002). Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res17:1441–1451.
26.
Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, et al. (1997). A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA94:13215–13220.
